An apparatus includes multiple first reservoirs and multiple second reservoirs joined with a substrate. Selected ones of the multiple first reservoirs include a reducing agent, and first reservoir surfaces of selected ones of the multiple first reservoirs are proximate to a first substrate surface. Selected ones of the multiple second reservoirs include an oxidizing agent, and second reservoir surfaces of selected ones of the multiple second reservoirs are proximate to the first substrate surface.

The invention is a regenerative pod for premature babies.

Disclosed herein are modules for performing hyperbaric oxygen therapy (HBOT) on a patient submerged in pressurized water where substantially no gas is present in the module. The modules generally have an entry, a fluid inlet for introducing water into the module, first and second fluid outlets positioned substantially at a base and a top of the module respectively, and a utilities inlet and outlet in part for transferring breathing air to and from the patient. The module permits HBOT treatment on a patient submerged in water with no air in the module, thus reducing the risk of fire or explosion. Methods and systems are also contemplated. Disclosed herein are methods of filling a module with water until there is substantially no gas in the module, and providing the patient in the module with treatment air during HBOT treatment.

The present magnetic and electromagnetic equipment achieves the molecular modification of liquid and gaseous fluids combustible or non-combustible by combining magnetic turbulence. The device combines magnetic and electromagnetic fields for producing magnetic turbulence that modifies the atomic behavior diamagnetic materials to be processed by the covalence thereof, improving the assimilation of fluids in humans by increasing the surfactant quality of the fluids in physical states.

An apparatus includes multiple first reservoirs and multiple second reservoirs joined with a substrate. Selected ones of the multiple first reservoirs include a reducing agent, and first reservoir surfaces of selected ones of the multiple first reservoirs are proximate to a first substrate surface. Selected ones of the multiple second reservoirs include an oxidizing agent, and second reservoir surfaces of selected ones of the multiple second reservoirs are proximate to the first substrate surface.

A method for noninvasive treatment of diabetic retinopathy helps prevent and reverses diabetic retinopathy and other vascular retinopathies, such as diabetic macular edema for a patient. The method comprises administering at least 80 percent pure oxygen to a patient in an oxygen chamber or nasal cannula. The oxygen chamber includes light emitting diodes that emit a light having a wavelength between 630-700 nm wavelengths on the patient. The method also includes administering an anti-inflammatory agent; an anti-oxidant; at least one of the following: an amino acid, arginine, and citrulline; and an omega-3 fatty acids to the patient. In extreme cases of diabetic retinopathy, a cold laser therapy is also administered to the patient with a wavelength between 570 nanometers and 1000 nanometers. The combination of all the aforementioned treatment modalities and compositions that work to synergistically to achieve unexpected clinical results for prevention and reversal of diabetic retinopathy.

A controller is operable to selectively supply gas to, and evacuate gas from, regions of a hyperbaric wound treatment chamber. The controller operates to inflate a passage or rib of the device to provide that the device is made sufficiently rigid for inserting a limb therethrough, and inflate an inflatable cuff to create a seal against the limb. The controller also operates to evacuate ambient air trapped within the chamber, and optionally partially evacuate the passage or rib, after the seal is created by the inflatable cuff, and then introduce oxygen into the chamber, and optionally inflate the passage or rib. The cuff, when inflated and creating a seal against a limb, optionally is at least partially within the chamber, and the treatment gas is supplied to the chamber to maintain the seal of the cuff against the limb.

A portable, personal therapy chamber for provision of infrared radiation therapy. The therapy chamber includes a pair of telescopically positionable cabins that are lightweight and easily portable by a single user. The therapy chamber is configured for use by a single person lying generally prone on a surface. The cabins are disposed to overlie the user and include a plurality of infrared radiation elements that direct infrared energy toward the user's body. When using the therapy chamber, the user's head extends from an open end of the cabin. A facial treatment fixture is integrated with the cabin to be extendable longitudinally from a terminal end thereof and to overlie the user's face/head. The therapy chamber can be configured to provide mild hyperbaric oxygen therapy in addition to infrared therapy.

An eyesight improvement method operable to reduce or eliminate the effects of eye disease such as but not limited to presbyopia wherein the present invention deploys utilization of a hyperbaric chamber. The present invention includes utilization of a hyperbaric chamber wherein the participant in the method of the present invention will engage in a consecutive quantity of treatment sessions to be executed during a prescribed treatment term. The treatment sessions can range from fifteen to one hundred and fifty minutes with a preferred embodiment time of ninety minutes. The pressure within the hyperbaric chamber is set at a range of one and a half to two and a half atmospheric pressure with a preferred pressure at two atmospheric pressure. The preferred embodiment includes a treatment term of three months with a range being between one and five months.

A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.